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Preclinical models of Alzheimer's disease (AD) suggest that volumetric reductions in medial temporal
lobe (MTL) structures manifest before clinical onset. AD polygenic risk scores (PRSs) are further linked to
reduced MTL volumes (the hippocampus/amygdala); however, the relationship between the PRS and
specific subregions remains unclear. We determine the relationship between the AD-PRSs and MTL
subregions in a large sample of young participants (N ¼ 730, aged 22e35 years) using a multimodal
(T1w/T2w) approach. We first demonstrate that the PRSs for the hippocampus/amygdala predict their
respective volumes and specific hippocampal subregions (pFDR < 0.05). We further observe negative
relationships between the AD-PRSs and whole hippocampal/amygdala volumes. Critically, we demon-
strate novel associations between the AD-PRSs and specific hippocampal subfields such as CA1 (b ¼
0.096, pFDR ¼ 0.045) and the fissure (b ¼ 0.101, pFDR ¼ 0.041). We provide evidence that the AD-PRS
is linked to specific MTL subfields decades before AD onset. This may help inform preclinical models of
AD risk, providing additional specificity for intervention and further insight into mechanisms by which
common AD variants confer susceptibility.
 2020 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Genome-wide association studies (GWAS) demonstrate that
Alzheimer's disease (AD) is substantially heritable (58%e78%),
where a substantial proportion of this variance can be explained by
cumulative polygenic effects (Gatz et al., 2006). Polygenic risk
scores (PRS) are a powerful approach for detecting AD risk decades
before the onset of disease by combining the cumulative effect of
individual single-nucleotide polymorphisms (SNPs) (Long et al.,
2017) and explaining 23%e53% heritability (Lee et al., 2018; Ridge
et al., 2013, 2016).
Several preliminary studies have explored the influence of indi-
vidual SNPs identified via AD GWAS such as loci within APOE, CLU,
BIN1, or PICALM on brain structure and function, broadly suggesting
that common variation within these genes are associated with AD
and may influence brain structure and function decades before dis-
ease onset (Chauhan et al., 2015; Ferencz et al., 2014; Sperling et al.,
2011; Trachtenberg et al., 2012; Yang et al., 2016; Zhang et al., 2015).in Research Imaging Centre
ersity, School of Psychology,
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ncaster).
Inc. This is an open access articleHowever, these variants have a modest effect in predicting AD and
related pathophysiology. The PRS based on the most recent GWAS
have considerably more predictive utility for AD risk (Escott-Price
et al., 2015, 2017). Although AD-PRSs hold promise for understand-
ing how to predict AD, the mechanisms by which the combined ef-
fects of the AD SNPs confer susceptibility is relatively unknown.
Imaging genetics is one such approach, which may help reveal the
neurobiological mechanisms bywhich genetic loci confer risk for AD.
Neuroimaging studies have consistently observed both global
and local atrophic changes during early stages of AD in the medial
temporal lobe (MTL) structures, including the amygdala, hippo-
campus, entorhinal cortex (ERC), and parahippocampal gyrus
(Braskie et al., 2013; Jack and Holtzman, 2013; Petrella et al., 2003;
Poulin et al., 2011; Serra et al., 2010; Thangavel et al., 2008). Both
the hippocampus and amygdala are key subcortical nodes affected
in AD-linked neurodegeneration (Hampel et al., 2014; Petrella et al.,
2003; Poulin et al., 2011); however, they are not homogenous
structures and comprise of a number of interconnected anatomi-
cally and functionally distinct subfields (Bocchetta et al., 2019;
Saygin et al., 2017). Specific hippocampal subfields may be more
susceptible to atrophy in those with AD compared with healthy
controls; such as the ERC, subiculum, CA1, CA3, dentate gyrus, and
CA4 (Gomez-Isla et al., 1996; Price et al., 2001; Wisse et al., 2014),under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
A.N. Murray et al. / Neurobiology of Aging 98 (2021) 33e4134suggesting that AD pathophysiology may have disproportionate
influence on specific hippocampal architecture.
Combining AD-PRS and neuroimaging data may help improve
AD detection strategies (Serra et al., 2010) by identifying precise
markers of early AD risk (Braskie et al., 2011; Whalley et al., 2012)
before the manifestation of clinical symptoms. Furthermore, recent
GWAS studies show that hippocampal and amygdala volumes are
also heritable (Di Paola et al., 2007; Sperling et al., 2011), making
them attractive candidates to probe for AD genetic effects. These
regions have also provided utility in anticipating mild cognitive
impairment to AD (Braskie et al., 2013; Hampel et al., 2014; Jack and
Holtzman, 2013; Petrella et al., 2003; Poulin et al., 2011; Serra et al.,
2010). One preliminary study linked AD-PRS to an increased rate of
volume decline in the ERC and the subiculum (Harrison et al., 2016);
however, this observation was based on an AD-PRS of the GWAS
loci/family history in a small sample (N ¼ 66), so the relationship
between the broad genetic architecture of AD and MTL subregions
across a broad population remains largely unresolved.
In the present study, we determine the association between AD
GWAS loci and specific MTL subfields and subnuclei in a large,
asymptomatic sample (N ¼ 1109, ages 2235 years). We anticipate
that AD-PRS will be negatively correlated with these subfield/sub-
nuclei volumes based on prior studies of whole MTL volume (Biffi
et al., 2010; Foley et al., 2017; Lancaster et al., 2019; Lupton et al.,
2016; Mormino et al., 2016). We further aim to determine that
polygenic contributions to the amygdala and hippocampus are
reliably measured using recent hippocampus and amygdala GWAS
as training data (Hibar et al., 2017; Satizabal et al., 2019).2. Methods
2.1. Magnetic resonance imaging data acquisition
Data were drawn from the March 2017 public data release from
the Young Human Connectome Project (YA-HCP) database. The
WU-MinnHCP 1200 Subjects Release (S1200) includes 1109 healthy
young adult participants’ T1 and T2 structural MR scans, available to
download at https://db.humanconnectome.org/app/template/
Login.vm. Participants were aged 22e35 years for all inclusion/
exclusion criteria (Van Essen et al., 2013). We restricted the HCP to
participants who self-reported Caucasian descent to minimize
ethnicity differences between the training GWAS and the MRI data
samples (see Table 1 for further demographic details). Protocol used
a customized Siemens 3T “Connectome Skyra” that increases the
maximum gradient strength from 40 mT/m to 100 mT/mwith a 32-
channel head coil and Siemens product (MPRAGE and SPACE) se-
quences. To acquire T1-weighed images, the protocol included slice
thickness 5.0 mm, TR 2.4 ms, TE 2.14 ms, TI 1000 ms, BW 210 Hz/Px,
and flip angle 8. T2-weighed image acquisition protocol included
TR 3.2 ms, TE 565 ms, BW 744 Hz/Px, and variable flip angles. Both
protocols used 224  224 mm field of view and 0.7 mm isotropicTable 1
Participant demographics





Age 29.04 3.61 28.88
Education 15.08 1.7 15.09
eTIV 1,603,258.84 176,743.26 1,600,579.0
Sex was tested using c2 test. All other demographics were tested via 2-sample t-test.
Key: Education, number of years; eTIV, estimated total intracranial volume; M, mean; SDvoxel size. Scan protocol and information on the HCP pedigree/
kinship structure can be found at http://www.humanconnectome.
org/storage/app/media/documentation/s1200/HCP_S1200_
Release_Reference_Manual.pdf.
2.2. Structural MRI preprocessing
The reconstructions of the subcortical volumes were carried out
using T1/T2-weighted images in FreeSurfer v6.0 software (http://
surfer.nmr.mgh.harvard.edu/). The standard “recon-all-all” pro-
cessing pipeline in FreeSurfer performed reliable automatic
subcortical segmentation (Brown et al., 2020) and skull stripping
after image motion correction and brain extraction on all subjects.
Subsequently, the segmentation of subcortical structures was
examined by a nonlinear warping atlas (31), and the volumetric
estimates (32) of the following hippocampal subfields for each
participant were obtained (see Fig. 1): CA1, CA2/3, CA4, pre-
subiculum, subiculum, hippocampal tail, parasubiculum, the mo-
lecular and granule cell layers of the dentate gyrus (GC.ML.DG), the
molecular layer, and the hippocampal amygdala transition area. The
ENIGMA Consortium Quality Control procedure for GWAS Meta-
Analysis of Subcortical Volumes (available at http://enigma.ini.
usc.edu/protocols/imaging-protocols/) was followed to identify
problematic boundaries in chosen subcortical regions of interest.
Preprocessed images were repurposed, and a FreeSurfer cross-
sectional pipeline was used (https://surfer.nmr.mgh.harvard.edu/
fswiki/HippocampalSubfieldsAndNucleiOfAmygdala) to obtain the
volumetric estimates of the following amygdala subnuclei for each
subject: lateral nucleus, basal nucleus, central nucleus, medial nu-
cleus, cortical nucleus, accessory basal nucleus, corticoamygdaloid
transition zone, anterior amygdaloid area, and the paralaminar
nucleus. The ENIGMA QC procedure excluded 10 participants from
statistical analysis due to rank violations.
2.3. Genetic quality control and PRS
All YA-HCP data are publicly available, including genome-wide
genotype data distributed through the database of Genotypes and
Phenotypes. SNPs were excluded where the minor allele frequency
was less than 1% if the call rate was less than 98% or if the c2 test for
Hardy-Weinberg equilibrium had a p > 1  104. Individuals were
excluded for ambiguous sex (genotypic sex and phenotypic sex not
aligning) or genotyping completeness less than 97%. A total of
1,137,480 variants and 1119 individuals were considered for PRS
creation. Participants that did not match the ethnicity of our dis-
covery sample GWAS were excluded from the analysis. PRS were
created using discovery data from 3 GWAS for hippocampal volume
(N ¼ 33,536; Hibar et al., 2017), amygdala volume (N ¼ 34,431;
Satizabal et al., 2019), and AD (NCASES ¼ 71,880, NCONTROLS ¼
373,378; Jansen et al., 2020), all of which were performed on par-





3.61 29.576 3.550 0.026
1.69 15.059 1.705 0.819
176,620.6 1,612,086.0 177,381.6 0.458
, standard deviation.
Fig. 1. Sagittal (upper row), coronal (middle row), and axial (lower row) images of the hippocampus and the amygdala subregions performed using FreeSurfer version 6.0
subcortical reconstruction. AAA, anterior amygdaloid area; GC.ML.DG, granule and molecular cell layer of dentate gyrus; HATA, hippocampal amygdala transition area.
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previously described (International Schizophrenia et al., 2009),
using PRSice software version 1.25 (Euesden et al., 2015). Briefly,
PRS were calculated using the “score” command in PLINK 2, which
averages the number of risk alleles for each index SNP weighted by
the beta coefficient for each of the 3 GWAS summary statistic files.
Clumping was applied to ensure that all index SNPs were inde-
pendent (500 kb, r ¼ 0.1). SNPs within the entire APOE locus
(chromosome 19: 44.4e46.5 Mb) were excluded to minimize as-
sociation because of variance in APOE. Due to the complexity of the
MHC region between 26 and 33 Mb on chromosome 6, SNPs in this
region were also removed. For each of the 3 models, nine PRS were
generated across a broad and comprehensive range of p value
thresholds (Escott-Price et al., 2017; So and Sham, 2017). The p
thresholds ranged from a conservative (including only GWAS sig-
nificant SNPs (p < 1  108) to all independent SNPs (p ¼ 1.0) at
logarithmic increments (p < 1 108; p < 1 107; p < 1 106; p
< 1105; p< 1104; p< 1103; p< 1102; p< 1101). A
wide p threshold range was chosen, as AD-PRS have been linked to
case-control status and related biomarkers using a range of con-
servative (Ge et al., 2018; Lupton et al., 2016) and liberal p thresh-
olds (Foley et al., 2017; Lancaster et al., 2019; Mormino et al., 2016).
Although liberal p thresholds offer more predictive power in pre-
dicting case/control differences (Escott-Price et al., 2015), they
contain more false positives, whereas conservative p thresholds are
estimated with proportionally more causal SNPs (Dudbridge, 2013).
The number of SNPs in each PRS model can be found in
Supplementary Table 1.
2.4. Power analysis
Post-hoc analysis was performed using R v3.5.2 with the
“pwr.r.test” function (Champely et al., 2018). The 2-sided approxi-
mate correlation power calculation with the complete imaging
sample size (N ¼ 730) at 0.05 a level and power of 80% to identify
associations explaining more than 1.07% variance. Based on our
prior observations between AD-PRS (excluding effects of APOE) andhippocampal volume in young adults and the lowest reported effect
size (R2 ¼ 1.6% Table 1 in a study by Foley et al., 2017), we had 93%
power to detect this effect in our current sample.
2.5. Statistical analysis
All analyses were performed in R v3.6.1. Linear mixed-effects
regression models were used to assess the influence of the PRS
models on individual subfields. As related individuals were
included in the sample (excluding half-siblings), a sparse kinship
matrix was created to control for the familial structure. The kinship
matrix was included in the LMEmodels using the “lme4qt” package
(Ziyatdinov et al., 2018), previously used to perform linear mixed
models regression in samples with latent kinship structure (Hall
et al., 2020; Lancaster, 2019). The AD-PRS and APOE e4 status
were included as fixed effects in addition to covariates, including
age, sex, years of education (SSAGA_Edu), estimated total intra-
cranial volume (eTIV: sum of the gray matter, white matter, and CSF
volumes) and the top 20 principal components derived from the LD
pruned data (R2 ¼ 0.1; 500 kb) to correct for population stratifica-
tion (Price et al., 2006). After removing participants that did not
match the original GWAS sample ethnicity (N ¼ 878), we further
removed participants with (1) missing data or (2) were identified as
statistical outliers using an outlier labeling rule (see below) for final
sample of 730. Each MRI volumetric measure was further pruned
based on an outlier detection protocol using the interquartile range
outlier labeling rule (1.5 interquartile range [Q3Q1]). False
discovery rate (FDR) was used to control for type I error across the
whole experiment across all 414 observations, including all sub-
regions, PRS models, and p thresholds.
3. Results
3.1. Hippocampus and amygdala PRS effects
After FDR correction across all observations, we identified
several positive associations between hippocampus PRS and whole
A.N. Murray et al. / Neurobiology of Aging 98 (2021) 33e4136hippocampus (pT < 1  107, b ¼ 0.109, pFDR ¼ 0.014) and specific
hippocampal subregions (including CA1, CA4, GC.ML.DG, molecular
layer, subiculum). Furthermore, we identified FDR-corrected posi-
tive associations between amygdala PRS and corticoamygdaloid
transition zone, anterior amygdaloid area and the lateral nucleus.
Amygdala PRS was positively related to whole amygdala but was
not significant after FDR correction (pT < 1106; b¼ 0.077, pFDR ¼
0.059). See Fig. 2, Table 2, and Supplementary Table 2 for all
estimates.3.2. AD PRS effects
We first provide further evidence for a negative association
between AD-PRS and whole hippocampal/amygdala volume.
However, these were not significant after FDR correction (hippo-
campus: pT < 1  104; b ¼ 0.072, pFDR ¼ 0.090, amygdala: pT <
1  105; b ¼ 0.073, pFDR ¼ 0.069). Critically, we observe novel,
FDR-corrected associations between AD-PRS and specific hippo-
campal subfields such as CA1 (pT < 1  104; b ¼ 0.096, pFDR ¼
0.045) and the fissure (pT < 1  105: b ¼ 0.101, pFDR ¼ 0.041;
Fig. 3). See Table 2 and Supplementary Table 3 for all estimates.3.3. APOE ε4 effects
A post-hoc analysis of APOE ε4 absence/presence and volume of
the 23 regions of interest demonstrated no associations (p> 0.05, inFig. 2. Positive control results: standardized b coefficients (Y-axis) for (A) hippocampus and (
p thresholds (X-axis). *Nominal significance (pUNCORRECTED < 0.05), **Survival for FDR (pFDRall cases). A comprehensive analysis (b, standard error of the b and p
values, for all subregions) is documented in Supplementary Table 4.
4. Discussion
We aimed to ascertain the combined role of GWAS-identified
SNPs on MTL subvolumes, specifically within the subfields and
subnuclei of the hippocampus and amygdala, respectively. Our first
objective was to provide a positive control by establishing repro-
ducible associations between hippocampus and amygdala volumes
and their respective PRS. Our observations show that hippocampus
and amygdala PRS are associated with gross volume of these
structures in an independent sample. Furthermore, we provide
novel evidence that PRS for both the hippocampus and amygdala
may be disproportionally influenced by specific regions within the
hippocampal (CA1, CA4, GC.ML.DG, molecular layer , subiculum)
and amygdala subregions (corticoamygdaloid transition zone,
anterior amygdaloid area and the lateral nucleus). These observa-
tions show that the PRS models hold critical predictive capacity in
our experimental sample, suggesting the sample had power to
detect the combined effects of GWAS-identified alleles. However,
we observed that different p thresholds yielded mixed predictive
capacity, which could be explained by underpowered discovery
GWAS, training discovery sample, or methodological differences.
We further observed negative associations between AD-PRS and
both whole hippocampal and amygdala volumes at more conser-
vative p thresholds. This is consistent with prior observationsB) amygdala PRS (controlling for demographic and genetic confounds) across a range of
< 0.05).
Table 2
Linear mixed model regression results for PRS on hippocampal and amygdala subfields/subnuclei volumes, corrected for genetic and demographic confounds
Region of interest PT BETA SE p FDR
Hippocampus PRS (Hibar et al., 2017)
CA1 1E-08 0.126 0.031 0.000 0.013
CA1 1E-07 0.132 0.031 0.000 0.010
CA1 1E-06 0.112 0.031 0.000 0.021
CA1 1E-05 0.100 0.031 0.001 0.045
CA4 1E-08 0.091 0.030 0.002 0.048
CA4 1E-07 0.104 0.030 0.001 0.024
GC.ML.DG 1E-08 0.092 0.030 0.002 0.047
GC.ML.DG 1E-07 0.104 0.030 0.001 0.024
Molecular layer HP 1E-07 0.105 0.033 0.001 0.045
Subiculum 1E-08 0.102 0.032 0.001 0.045
Subiculum 1E-07 0.096 0.032 0.002 0.048
Whole hippocampus 1E-08 0.108 0.029 0.000 0.014
Whole hippocampus 1E-07 0.110 0.029 0.000 0.014
Amygdala PRS (Satizabal et al., 2019)
Anterior amygdaloid area 1E-05 0.098 0.031 0.002 0.046
Anterior amygdaloid area 1Eþ00 0.097 0.032 0.002 0.047
Corticoamygdaloid transition 1E-01 0.096 0.031 0.002 0.046
Corticoamygdaloid transition 1Eþ00 0.120 0.032 0.000 0.014
Lateral nucleus 1E-06 0.096 0.026 0.000 0.014
Lateral nucleus 1E-05 0.084 0.027 0.002 0.046
Alzheimer's PRS (Jansen et al., 2020)
CA1 1E-04 0.096 0.031 0.002 0.045
Hippocampal fissure 1E-05 0.101 0.031 0.001 0.041
Key: BETA, standardized beta coefficient; FDR, p value corrected for false discovery rate; PRS, polygenic risk score; PT, p threshold; SE, standard error of beta coefficient.
Fig. 3. Standardized b coefficients (Y-axis) for Alzheimer's disease PRS (controlling for demographic and genetic confounds) across a range of p thresholds (X-axis) for (A) hip-
pocampal and (B) amygdala subregions. *Nominal significance (pUNCORRECTED < 0.05), **Survival for FDR (pFDR < 0.05).
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the p < 0.0001 threshold) in younger (Foley et al., 2017) and older
adults (Lupton et al., 2016), where the AD-PRS explained 3.9% and
0.3% in whole hippocampal volume, respectively. This p threshold
could reflect an optimal combination of causal SNPs (less false
positives) and power (from polygenic effects). The association be-
tween AD-PRS and the amygdala is also consistent with a recent
GWAS of hippocampus and amygdala, showing negative genetic
correlations with AD (Hibar et al., 2017; Satizabal et al., 2019) and
consistent with existing evidence linking AD-PRS and MTL volume
structure volume variation. More broadly, several studies have
linked AD-PRS to variation in brain structure at different points
across the lifespan (Axelrud et al., 2018; Foley et al., 2017; Lancaster
et al., 2019; Lupton et al., 2016; Mormino et al., 2016). Our second
objective was to quantify the relationship between AD-PRS and
hippocampal/amygdala subfields. Hippocampal atrophy in sub-
regions, such as CA1 and the subiculum, may be indicative markers
of future AD-linked decline beyond whole hippocampal volume
(Hett et al., 2019; Kerchner et al., 2010, 2012; Khan et al., 2015; La
Joie et al., 2013; Vasta et al., 2016). After correcting for FDR, we
observed the strongest negative associations between AD-PRS and
hippocampal subregions were in CA1 and the fissure. Both CA1 and
the fissure have also recently been implicated as AD-vulnerable
MTL subregions (Wisse et al., 2014; Zhao et al., 2019). Atrophy
within CA1 has further been linked to reduced neuronal count
(Blanken et al., 2017).
The present study must be interpreted with the following con-
siderations. First, the spatial resolution provided by the 3T MRI
data. Precise subfield boundary separation is difficult at the reso-
lution achievable within a reasonable scan time at this field
strength. Although each segmentation was statistically and visually
checked for segmentation errors, small volume subfields (e.g., the
hippocampal amygdala transition area and parasubiculum) or thin
regions (e.g., the ML.CG.DL) may be more difficult to resolve/error
prone. We further note that the predictive performance of the
positive control PRS (hippocampus/amygdala) was broadly superior
in larger subregions. As the hippocampal/amygdala PRS are derived
fromwhole hippocampal/amygdala volumes, sample variance may
be disproportionally accounted for by the larger subregions. An
alternative explanation is that the large subregions are more stable/
less susceptible to artifacts in the segmentation procedure. We
suggest that disproportionate measurement error across sub-
regions could be a technical confound for all MTL segmentation
studies and inference regarding smaller subregions should be
interpreted with caution. Second, despite minimizing population
effects by excluding non-Caucasian participants and including 20
principal components as covariates, we cannot fully exclude pop-
ulation stratification effects or any residual kinship structure that
may influence our results. We also note that these inferences are
restricted to Caucasian populations to match the discovery GWAS
used as training data. We suggest that future transethnic GWASwill
be necessary to broaden the generalizability of the inferences and
take full advantage of ethnically mixed MRI cohorts, such as HCP.
Third, it is difficult to determine the longitudinal impact of AD-PRS
because of the cross-sectional design of this study. Future studies
that assess development/aging will help to understand the impact
of AD-PRS on MTL volumetry across the lifespan (Bookheimer et al.,
2019; Harms et al., 2018; Somerville et al., 2018). However, as our
sample is of young adults (aged 22e35 years), we would suggest
that accumulated environmental factors linked to reduced MTL
structure (e.g., smoking, diabetes [Durazzo et al., 2013; Li et al.,
2020]) have limited impact, as these are accumulated over an
individual's lifespan. Finally, we also note that pleotropic variants/
shared genetic architecture between AD and cognition may also
influence brain volumes such as the hippocampus and amygdala(Hill et al., 2016; Luciano et al., 2015; Maglanoc et al., 2020). To
conclude, our observations may help to establish processes by
which polygenic variation may influence specific nuclei in AD-
vulnerable MTL volumes. Future studies investigating biologically
informed pathways may further help us to understand how AD
biomarkers are influenced by genetic risk (Ahmad et al., 2018;
Lancaster et al., 2019). Furthermore, advanced multivariate GWAS
may help to establish specific, shared risk loci and biological
mechanisms between AD and MTL volumes (Broce et al., 2019;
Yokoyama et al., 2016). Refining AD-PRS and MRI strategies for MTL
subregions may help refine preclinical imaging biomarkers for AD
risk detection and treatment strategies.
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